Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.52 is 86% below its 5-year average of 10.67, near the low end of its 5-year range (1.52–24.03).
As of the fiscal period ended Tuesday, June 30, 2026. 47.74% below its 12-month average of 2.91.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.52.
QUICK RATIO (ACID-TEST)
1.52
QUICK RATIO (ACID-TEST) AVG TTM
2.91
QUICK RATIO (ACID-TEST) AVG 3Y
6.64
QUICK RATIO (ACID-TEST) AVG 5Y
10.67
QUICK RATIO (ACID-TEST) AVG 10Y
9.34
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-47.74%
CURRENT VS 3Y AVG
-77.11%
CURRENT VS 5Y AVG
-85.76%
CURRENT VS 10Y AVG
-83.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-54.71%
vs the sector median at left
Co-Diagnostics, Inc.
Market Cap
$7.19M
Quick Ratio (Acid-Test)
1.52
TTM Avg
2.91
3Y Avg
6.64
5Y Avg
10.67
Market Cap
$7.19M
Quick Ratio (Acid-Test)
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.52
Market Cap
$7.15M
Quick Ratio (Acid-Test)
2.63
TTM Avg
4.46
3Y Avg
3.65
5Y Avg
4.69
Market Cap
$7.12M
Quick Ratio (Acid-Test)
0.95
TTM Avg
9.81
3Y Avg
5.30
5Y Avg
4.51
Market Cap
$7.31M
Quick Ratio (Acid-Test)
1.37
TTM Avg
3.92
3Y Avg
4.12
5Y Avg
3.73
Market Cap
$7.07M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.62M
Quick Ratio (Acid-Test)
14.52
TTM Avg
3.29
3Y Avg
11.30
5Y Avg
10.20
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $7.19M | 1.52 | 2.91 | 6.64 | 10.67 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.19M | 0.31 | 1.26 | 1.91 | 5.52 |
| Longeveron Inc. (LGVN)vs › | $7.15M | 2.63 | 4.46 | 3.65 | 4.69 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | 0.95 | 9.81 | 5.30 | 4.51 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 1.37 | 3.92 | 4.12 | 3.73 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | 45.95 | 58.73 | 40.89 | 40.89 |
| KALA BIO, Inc. (KALA)vs › | $7.04M | 6.88 | 3.46 | 4.15 | 4.53 |
| Exicure, Inc. (XCUR)vs › | $6.88M | 0.56 | 2.82 | 3.15 | 3.36 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | 14.52 | 3.29 | 11.30 | 10.20 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | 0.18 | 0.90 | 2.06 | 1.76 |
Quick Ratio
1.52
Excludes inventory
Current Ratio
1.81
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.52 |
| 2026-03-31 | 2.09 |
| 2025-12-31 | 3.59 |
| 2025-09-30 | 3.51 |
| 2025-06-30 | 3.83 |
| 2025-03-31 | 4.23 |
| 2024-12-31 | 4.27 |
| 2024-09-30 | 6.70 |
| 2024-06-30 | 8.81 |
| 2024-03-31 | 9.90 |
| 2023-12-31 | 10.52 |
| 2023-09-30 | 13.10 |
| 2023-06-30 | 14.21 |
| 2023-03-31 | 22.33 |
| 2022-12-31 | 22.57 |
| 2022-09-30 | 16.05 |
| 2022-06-30 | 16.36 |
| 2022-03-31 | 9.25 |
| 2021-12-31 | 8.98 |
| 2021-09-30 | 24.03 |
| 2021-06-30 | 18.23 |
| 2021-03-31 | 16.94 |
| 2020-12-31 | 14.86 |
| 2020-09-30 | 22.72 |
| 2020-06-30 | 8.18 |
| 2020-03-31 | 15.86 |
| 2019-12-31 | 4.23 |
| 2019-09-30 | 9.96 |
| 2019-06-30 | 14.59 |
| 2019-03-31 | 16.47 |
| 2018-12-31 | 0.44 |
| 2018-09-30 | 1.09 |
| 2018-06-30 | 6.13 |
| 2018-03-31 | 10.98 |
| 2017-12-31 | 7.07 |
| 2017-09-30 | 8.67 |
| 2017-06-30 | 0.07 |
| 2017-03-31 | 0.15 |
| 2016-12-31 | 0.31 |
| 2016-09-30 | 0.07 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.15 |
